BMY•benzinga•
BMO Capital Maintains Market Perform on Bristol-Myers Squibb, Raises Price Target to $57
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 1, 2024 by benzinga